Concepedia

David M. Weiner

DM

47

Publications

4.2K

Citations

30

H-Index

1947

Active since

Affiliations

Acadia Pharmaceuticals (United States)(Current)

University of California San Diego

National Institute of Neurological Disorders and Stroke

Columbia University

University of Pennsylvania

David M. Weiner is an author at Acadia Pharmaceuticals (United States) specializing in medicine, pharmacology, and neuropharmacology.

ORCID

Top concepts

Publications per year

1947–2020

47

Publications

47

D1 and D2 dopamine receptor mRNA in rat brain.

David M. Weiner, Allan I. Levey, Roger K. Sunahara et al. · Proceedings of the National Academy of Sciences · 1991 · 484 citations · Full text

, , +15

Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia.

David M. Weiner, Allan I. Levey, Mark R. Brann · Proceedings of the National Academy of Sciences · 1990 · 477 citations · Full text

, , +21

Human dopamine D1 receptor encoded by an intronless gene on chromosome 5

Roger K. Sunahara, Hyman B. Niznik, David M. Weiner et al. · Nature · 1990 · 465 citations

, , +8

The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine

David M. Weiner, Herbert Y. Meltzer, Isaac Veinbergs et al. · Psychopharmacology · 2004 · 249 citations

, , +7

5-Hydroxytryptamine2A Receptor Inverse Agonists as Antipsychotics

David M. Weiner, Ethan S. Burstein, N. T. Nash et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 201 citations

Rows per page

1–5 of 47